Patented Medicine Prices Review Board (PMPRB)

Ensuring Canada remains an attractive destination for pharmaceutical innovation.

The Patented Medicine Prices Review Board (PMPRB) ensures patented medicines sold in Canada are not excessively priced. IMC has highlighted how changes to the PMPRB affect patient access to medicines and Canada’s attractiveness for future pharmaceutical innovation.


Breaking down and analyzing current events in the healthcare industry for our members, policy influencers and the Canadian public.


Our member companies, which range from early-stage startups to established organizations, are revolutionizing healthcare through the discovery and development of new […]


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.